BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1622120)

  • 1. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
    Tsujitani S; Kakeji Y; Orita H; Watanabe A; Kohnoe S; Baba H; Anai H; Maehara Y; Sugimachi K
    Anticancer Res; 1992; 12(3):645-8. PubMed ID: 1622120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
    Imaizumi M; Kondo T; Kamei H; Ichihashi H
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
    Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
    Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
    Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years.
    Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
    Jpn J Surg; 1988 Nov; 18(6):681-6. PubMed ID: 3150019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].
    Mitomi T; Kyoji-Ogoshi
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2532-7. PubMed ID: 3090939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
    Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
    Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
    J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
    Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
    Ichihashi H; Kondo T; Nakazato H
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery and adjuvant therapy of gastric cancer].
    Tamada R
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1555-63. PubMed ID: 3089173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.
    Hattori T; Nakajima T; Nakazato H; Tanabe T; Kikuchi K; Abe O; Kondo T; Taguchi T; Komi N; Sugimachi K
    Jpn J Surg; 1990 Mar; 20(2):127-36. PubMed ID: 2111414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
    Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma].
    Kanabe S; Tamakuma S; Mimura K; Hiraide H; Mochizuki H; Tamaki K; Kurokawa T; Kadota T; Hatsuse K; Kawano M
    Gan No Rinsho; 1985 Nov; 31(14):1805-9. PubMed ID: 3936946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
    Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondou T; Abe O; Kikuchi K; Tanabe T; Ogawa N
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):799-806. PubMed ID: 2496668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer.
    Iino Y; Yokoe T; Maemura M; Horiguchi J; Takei H; Ohwada S; Morishita Y
    Anticancer Res; 1995; 15(6B):2907-11. PubMed ID: 8669887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
    Kondo T; Sakamoto J; Nakazato H
    Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
    Maehara Y; Okuyama T; Kakeji Y; Baba H; Furusawa M; Sugimachi K
    Am J Surg; 1994 Jul; 168(1):36-40. PubMed ID: 8024097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.